Back to Agenda
The Evolving Clinical Trial Disclosure Global Landscape
Session Chair(s)
Robert Paarlberg, MS
Principal
Paarlberg & Associates LLC, United States
This session will present the current disclosure landscape, identify important global developments, discuss the potential impact that increased disclosure will have on clinical research, and identify how best to prepare for the future.
This session has been developed by the Clinical Trial Disclosure Community.
Learning Objective : Recognize the recent events that are shaping the disclosure landscape; Evaluate how one company’s announcement to provide open access to data tables may influence clinical research; Assess how trial sponsors are preparing for disclosure of patient-level data, lay summaries and unredacted CSRs.
Speaker(s)
Panelist
Rebecca Li, PhD
Vivli , United States
Executive Director, Center for Global Clinical Research Data
Panelist
Jacqueline Cole, MS
Eli Lilly and Company, United States
Oncology Clinical Operations Portfolio Management, NA Clinical Operations
Panelist
Jessica S. Scott, JD, MD
Legacy Health Strategies , United States
President
Panelist
Robert Paarlberg, MS
Paarlberg & Associates LLC, United States
Principal
Have an account?